• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病患者的高血压:最新文献综述

Hypertension in Patients With Peripheral Artery Disease: An Updated Literature Review.

作者信息

Abraham Andrew T, Mojaddedi Sanaullah, Loseke Isaac H, Bray Christopher

机构信息

Graduate Medical Education/North Florida Regional Medical Center, University of Central Florida College of Medicine, Gainesville, USA.

出版信息

Cureus. 2024 Jun 12;16(6):e62246. doi: 10.7759/cureus.62246. eCollection 2024 Jun.

DOI:10.7759/cureus.62246
PMID:39006738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11245047/
Abstract

Peripheral artery disease (PAD), a condition where there is reduced blood flow due to narrowing or blockage of the arteries of the peripheral vasculature, is an epidemic that currently affects eight million people in the United States alone and is a major risk equivalent to having active coronary artery disease (CAD). However, it is commonly underdiagnosed in the general population. Hypertension is a common cardiovascular condition characterized by elevated blood pressure levels. There are several mitigating risk factors that can reduce the risk of complications of PAD, with hypertension playing a major role. This literature review aims to explore the relationship between hypertension and PAD, including their shared risk factors, pathophysiological mechanisms, and management strategies. In addition, we will analyze how this impacts major cardiovascular outcomes, such as critical limb ischemia, vascular amputation, myocardial infarction (MI), ischemic stroke, and cardiovascular-related death by examining relevant studies, current guidelines, and evidence. This literature review is intended to guide practitioners on ideal blood pressure parameters and evidence-based anti-hypertensives that provide overall cardiovascular benefit in both the primary care and hospital-based setting. By understanding the association between hypertension and PAD and the underlying pathophysiological mechanisms, healthcare professionals can improve diagnosis, treatment, and management strategies for affected individuals.

摘要

外周动脉疾病(PAD)是一种由于外周血管系统动脉狭窄或阻塞导致血流减少的疾病,是一种流行病,目前仅在美国就影响着800万人,并且是与患有活动性冠状动脉疾病(CAD)相当的主要风险因素。然而,它在普通人群中常常未被诊断出来。高血压是一种常见的心血管疾病,其特征是血压水平升高。有几种可减轻风险的因素能够降低PAD并发症的风险,其中高血压起着主要作用。这篇文献综述旨在探讨高血压与PAD之间的关系,包括它们共同的风险因素、病理生理机制和管理策略。此外,我们将通过研究相关研究、现行指南和证据,分析这如何影响主要的心血管结局,如严重肢体缺血、血管截肢、心肌梗死(MI)、缺血性中风和心血管相关死亡。这篇文献综述旨在指导从业者了解理想的血压参数以及在初级保健和医院环境中均能提供总体心血管益处的循证抗高血压药物。通过了解高血压与PAD之间的关联以及潜在的病理生理机制,医疗保健专业人员可以改善对受影响个体的诊断、治疗和管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924c/11245047/bc2300e4007c/cureus-0016-00000062246-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924c/11245047/e0f9585f5b7d/cureus-0016-00000062246-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924c/11245047/bc2300e4007c/cureus-0016-00000062246-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924c/11245047/e0f9585f5b7d/cureus-0016-00000062246-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924c/11245047/bc2300e4007c/cureus-0016-00000062246-i02.jpg

相似文献

1
Hypertension in Patients With Peripheral Artery Disease: An Updated Literature Review.外周动脉疾病患者的高血压:最新文献综述
Cureus. 2024 Jun 12;16(6):e62246. doi: 10.7759/cureus.62246. eCollection 2024 Jun.
2
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.下肢外周动脉疾病的支架置入术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.
3
4
Treatment of hypertension in peripheral arterial disease.外周动脉疾病中高血压的治疗
Cochrane Database Syst Rev. 2013 Dec 4;2013(12):CD003075. doi: 10.1002/14651858.CD003075.pub3.
5
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).依洛尤单抗降低低密度脂蛋白胆固醇水平及外周动脉疾病患者的结局:来自 FOURIER 试验(在高风险人群中用 PCSK9 抑制剂进行进一步心血管结局研究)的见解。
Circulation. 2018 Jan 23;137(4):338-350. doi: 10.1161/CIRCULATIONAHA.117.032235. Epub 2017 Nov 13.
6
Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.多血管疾病与外周动脉疾病主要不良心血管事件风险:EUCLID 试验的二次分析。
JAMA Netw Open. 2018 Nov 2;1(7):e185239. doi: 10.1001/jamanetworkopen.2018.5239.
7
Association of Ankle-Brachial Indices With Limb Revascularization or Amputation in Patients With Peripheral Artery Disease.踝臂指数与外周动脉疾病患者肢体血运重建或截肢的相关性。
JAMA Netw Open. 2018 Dec 7;1(8):e185547. doi: 10.1001/jamanetworkopen.2018.5547.
8
Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study.利伐沙班用于下肢外周动脉疾病血运重建术后有症状患者的双抗血栓和抗血小板治疗比较:一项回顾性队列研究
Ther Adv Chronic Dis. 2023 Dec 6;14:20406223231213262. doi: 10.1177/20406223231213262. eCollection 2023.
9
Ankle brachial index for the diagnosis of lower limb peripheral arterial disease.踝臂指数用于诊断下肢外周动脉疾病。
Cochrane Database Syst Rev. 2016 Sep 14;9(9):CD010680. doi: 10.1002/14651858.CD010680.pub2.
10
Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease.1 型和 2 型糖尿病合并外周动脉疾病患者的肢体和心血管事件风险。
Vasa. 2023 Sep;52(5):310-316. doi: 10.1024/0301-1526/a001086. Epub 2023 Jul 31.

引用本文的文献

1
Serum -Cresyl Sulfate Levels Correlate with Peripheral Arterial Disease in Hypertensive Patients.血清对甲酚硫酸盐水平与高血压患者外周动脉疾病相关。
Diagnostics (Basel). 2025 Apr 25;15(9):1097. doi: 10.3390/diagnostics15091097.

本文引用的文献

1
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS 下肢外周动脉疾病管理指南:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2024 Jun 18;83(24):2497-2604. doi: 10.1016/j.jacc.2024.02.013. Epub 2024 May 14.
2
Preventive Therapies in Peripheral Arterial Disease.外周动脉疾病的预防性治疗
Biomedicines. 2023 Nov 27;11(12):3157. doi: 10.3390/biomedicines11123157.
3
A Systematic Review of Interleukins as Diagnostic and Prognostic Biomarkers for Peripheral Artery Disease.
白细胞介素作为外周动脉疾病诊断和预后生物标志物的系统评价。
Biomolecules. 2023 Nov 12;13(11):1640. doi: 10.3390/biom13111640.
4
Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment.外周动脉疾病:病因、病理生理学、诊断及治疗的最新进展
Med Clin (Barc). 2023 Oct 27;161(8):344-350. doi: 10.1016/j.medcli.2023.06.005. Epub 2023 Jul 28.
5
Comparison of the Effectiveness and Safety of Chlorthalidone and Hydrochlorothiazide in Patients With Hypertension: A Meta-Analysis.氯噻酮与氢氯噻嗪治疗高血压患者的有效性和安全性比较:一项荟萃分析
Cureus. 2023 Apr 27;15(4):e38184. doi: 10.7759/cureus.38184. eCollection 2023 Apr.
6
Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia.经导管动脉化治疗慢性肢体缺血性疾病的深部静脉
N Engl J Med. 2023 Mar 30;388(13):1171-1180. doi: 10.1056/NEJMoa2212754.
7
Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease.尿胱抑素 C 在外周动脉疾病中有预后价值。
Biomolecules. 2022 Jun 21;12(7):860. doi: 10.3390/biom12070860.
8
Peripheral arterial disease and hypertension.外周动脉疾病与高血压。
Curr Opin Cardiol. 2022 Sep 1;37(5):403-412. doi: 10.1097/HCO.0000000000000983. Epub 2022 Jul 19.
9
Elevated C-Reactive Protein/Albumin Ratio Is Associated With Lesion Complexity, Multilevel Involvement, and Adverse Outcomes in Patients With Peripheral Artery Disease.C 反应蛋白/白蛋白比值升高与外周动脉疾病患者的病变复杂性、多水平受累和不良结局相关。
Angiology. 2022 Oct;73(9):843-851. doi: 10.1177/00033197221075853. Epub 2022 Mar 2.
10
Sex Differences in Peripheral Artery Disease.外周血管疾病的性别差异。
Circ Res. 2022 Feb 18;130(4):496-511. doi: 10.1161/CIRCRESAHA.121.320702. Epub 2022 Feb 17.